Katharina Barbara Küntzel

Katharina Barbara Küntzel is a Postdoctoral Researcher at the Department of Biomedical Sciences within the Faculty of Health and Medical Sciences at the University of Copenhagen. Her research focuses on endocrinology and metabolism, particularly investigating lipid metabolism disorders and their connections to liver disease. She is based at Blegdamsvej 3B in Copenhagen and maintains active research collaborations within her department and with international partners.

Dr. Küntzel's primary research interests center on lysosomal acid lipase (LAL) and its critical role in lipid metabolism. Her work explores the connections between LAL deficiency (LAL-D) and the newly classified MASLD (Metabolic dysfunction-associated steatotic liver disease). She investigates how lipid metabolism disruptions contribute to liver inflammation, fibrosis, and cancer development. Her research also extends to other lipases including monoglyceride lipase and adipose triglyceride lipase, examining their roles in thrombogenesis and cardiovascular health. Additional research areas include placental lipid metabolism in gestational diabetes and the signaling functions of liver-derived metabolites in fatty liver disease progression.

Analysis of her publication record reveals a strong focus on molecular mechanisms of lipid metabolism disorders. Her work consistently employs mouse models to investigate disease pathways, with particular attention to how enzyme deficiencies affect metabolic processes. Recent publications show increasing emphasis on translational aspects, connecting basic molecular findings to clinical manifestations of metabolic diseases. Her research demonstrates interdisciplinary approaches combining molecular biology, biochemistry, and pathophysiology to understand complex metabolic disorders.

Dr. Küntzel works within a prominent research group led by Dr. Kratky, focusing on lipid metabolism and related disorders. This collaborative environment enables comprehensive investigation of metabolic pathways from molecular mechanisms to disease outcomes. Her work contributes significantly to understanding the pathophysiology of metabolic liver diseases and related conditions.